Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

GTPy binding assay

Harrison, C. and J.R. Traynor. 2003. The [35S]GTPyS binding assay approaches and applications in pharmacology. Life Sci. 74, 489-508. [Pg.80]

Agonist potency (EC50) measured in [35S]GTPyS binding assays in membranes expressing human 5 receptors [46]... [Pg.129]

S]GTPyS binding assays. These new series of compounds resulted in the most selective 8 ligands so far described and from the chemistry point of view they have the advantages of not having chiral centers and being easily synthesized. [Pg.130]

Table 2 Pharmacological properties of compounds MCL-139 (13a) and MCL-144 (13b) for p and k opioid receptors in [35S]GTPyS binding assay... Table 2 Pharmacological properties of compounds MCL-139 (13a) and MCL-144 (13b) for p and k opioid receptors in [35S]GTPyS binding assay...
As to the endocannabinoid virodhamine. Porter et al. (2002) have shown that this activates both CBi and CB2 receptors. Their experiments with transfected cells yielded CBi and CB2 EC50 values in the GTPyS binding assay of 1.9 and... [Pg.17]

Diagram 21.1 pECso values of endogenous ligands for the HCA receptor family in human GTPyS binding assays. [Pg.598]

GPR81 Human Membrane lactate Second Messenger Radiometric - Filtration Agonist screen 10 pM compound concentration GTPyS binding assay... [Pg.600]

See other pages where GTPy binding assay is mentioned: [Pg.263]    [Pg.296]    [Pg.304]    [Pg.306]    [Pg.231]    [Pg.86]    [Pg.110]    [Pg.203]    [Pg.217]    [Pg.219]    [Pg.65]    [Pg.613]    [Pg.246]    [Pg.17]    [Pg.520]    [Pg.150]    [Pg.167]    [Pg.429]    [Pg.440]    [Pg.489]    [Pg.491]    [Pg.99]    [Pg.304]    [Pg.600]    [Pg.630]    [Pg.632]   
See also in sourсe #XX -- [ Pg.265 , Pg.267 , Pg.268 , Pg.272 ]



SEARCH



Binding assays

© 2024 chempedia.info